Would you like to take part in a Clinical Trial for a new investigational treatment for ankylosing spondylitis at no cost to you?

No health insurance is required to participate. You will receive all study related care from a specialist physician at no cost. The study will include visits to a clinic in your location.

Participants will receive compensation for participating in the study.

You may qualify for a clinical research study if you:

  • Are over the age of 18
  • Experience symptoms of Ankylosing Spondylitis such as:
    • Chronic neck and/or back pain
    • Back and hip stiffness
    • Fatigue
  • Have previously tried nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Aspirin, naproxen, or other NSAIDs to relieve your symptoms



Sign Up

If you think you might like to join this study or would like more information, please enter your information below so we can see if you qualify and can contact you about the study. Remember, participation is entirely voluntary. Even if you decide to take part, it is absolutely fine if you change your mind later.

About Ankylosing Spondylitis

Ankylosing Spondylitis and Axial Spondyloarthritis (axial SpA) are chronic inflammatory diseases that affect the spine, causing severe pain, stiffness and fatigue; varying from day-to-day. Typically, the symptoms of Ankylosing Spondylitis and Axial Spondyloarthritis begin during early adulthood, but may start at any age.

Ankylosing Spondylitis and Axial Spondyloarthritis often start the bottom of the spine, where the ligaments or tendons attach to the bone. Repeated inflammation can lead to further bone formation, and the vertebrae may begin to fuse together.1

Besides back pain alone, there are several other symptoms that are associated with Ankylosing Spondylitis and Axial Spondyloarthritis such as:

  • Gradual onset of back stiffness and pain over weeks or months
  • Feeling better after workouts and exercise
  • Fatigue and tiredness
  • Night sweats
  • Weightloss in the early stages

Regular exercise, stretching and NSAIDs, (such as diclofenac, ibuprofen, naproxen, celecoxib and etoricoxib) help many people relieve their symptoms. However, there are an outstanding number of Ankylosing Spondylitis and Axial Spondyloarthritis patients who have not seen improvement with or are unable to take NSAIDs due to safety or side effect reasons.

The Ankylosing Spondylitis Studies are evaluating an investigational drug for adults with Ankylosing Spondylitis or Axial Spondyloarthritis.

Frequently Asked Questions

What is a clinical research study?

A Clinical Research Study (also called a clinical trial) is a medical study that helps answer important questions about an investigational drug or device, such as: does it work, or how effective is it compared to another drug/device?

All medications must be tested in clinical research studies before they can be approved by regulatory authorities for doctors to prescribe to patients. Without people taking part in these studies, we would have no new treatments. The volunteers who participate in clinical research studies play a major role in helping to advance medicine.

The Ankylosing Spondylitis Studies will include various visits to a study clinic in your area and follow up phone calls at designated times.

All study-related care is provided at no cost to you. You do not need health insurance to participate.

Volunteers who take part in the study may receive compensation for their time and travel.
Participation is entirely voluntary. Even if you decide to take part in this study, you can change your mind about participating at any time.

There is no cost to participate in the Ankylosing Spondylitis Studies. If you qualify, the investigational drug, study-related tests, assessments, and visits will be provided to you at no cost. You will receive study-related care throughout the study from a team of professional doctors and nurses at no cost to you.

Volunteers who take part in the studies may be compensated for their time and travel. Please discuss this with the study team when they contact you.